Terephthalic Acid → HCID 178483021, compound

HRID 2284219Notes

Reaction equation

[CH3:1][N:2]([CH3:13])[C:3]1[NH:4][C:5]2[CH:11]=[C:10]([NH2:12])[CH:9]=[CH:8][C:6]=2[N:7]=1.[C:14]([OH:25])(=O)[C:15]1[CH:23]=[CH:22][C:18]([C:19]([OH:21])=O)=[CH:17][CH:16]=1>>[CH3:1][N:2]([CH3:13])[C:3]1[NH:7][C:6]2[CH:8]=[CH:9][C:10]([NH:12][C:19](=[O:21])[C:18]3[CH:17]=[CH:16][C:15]([C:14]([NH:12][C:10]4[CH:9]=[CH:8][C:6]5[NH:7][C:3]([N:2]([CH3:1])[CH3:13])=[N:4][C:5]=5[CH:11]=4)=[O:25])=[CH:23][CH:22]=3)=[CH:11][C:5]=2[N:4]=1

Participants

Reactant 2

HCID 7489Terephthalic Acid

HCID 45077873HCID 45077873, compound

Product 1

HCID 178483021HCID 178483021, compound

Procedure

Compound 435 was prepared according to the procedure similar to that described in Scheme V from 2-dimethylamino-5-aminobenzimidazole and terephthalic acid. [M+H]+ calcd for C26H26N8O2: 483.22; found: 483.02.

Sources & evidence

ORD record: ord-9bc02d4b43c741cda7d3fba01111c178
Source dataset: uspto-grants-2015_09
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US09144557B2

Reaction notes

Loading…